Exploring the pathologist's role in understanding COVID-19: from pneumonia to long-COVID lung sequelae.


Journal

Pathologica
ISSN: 1591-951X
Titre abrégé: Pathologica
Pays: Italy
ID NLM: 0401123

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 21 07 2023
accepted: 21 07 2023
medline: 7 12 2023
pubmed: 6 12 2023
entrez: 6 12 2023
Statut: ppublish

Résumé

The crucial role of pathologists in enhancing our understanding of SARS-CoV-2-related disease, from initial pneumonia manifestations to persistent long COVID lung symptoms, is the focus of this review. Pathological explorations have offered unprecedented insights into the early stages of severe COVID-19, shedding light on the interplay between the virus and subsequent complications, thereby shaping clinical approaches. Growing interest is directed to residual lung abnormalities of COVID-19 survivors. Although various radiological studies reported long-lasting pulmonary changes (e.g., ground glass opacities, reticulations, and bronchiectasis), the true incidence of pulmonary fibrosis and corresponding pathological findings in these patients remains largely unknown. There are a few high-impact and knowledgeable works on late complications in COVID-19 survivors, several coming from explant or autopsy cases, and rare cases from in vivo sampling. The study of biopsy samples has further deepened our knowledge of the aftermath of COVID-19 on lung tissue, uncovering alterations at the cellular level and shifts in vascular and epithelial dynamics. Despite the substantial progress made, future research is needed to devise a uniform strategy for interpreting lung biopsies, with a focus on leveraging advanced tools such as molecular and digital pathology techniques, along with artificial intelligence.

Identifiants

pubmed: 38054902
doi: 10.32074/1591-951X-906
pmc: PMC10699331
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

275-283

Informations de copyright

Copyright © 2023 Società Italiana di Anatomia Patologica e Citopatologia Diagnostica, Divisione Italiana della International Academy of Pathology.

Références

Lancet Respir Med. 2021 May;9(5):487-497
pubmed: 33811829
Am J Clin Pathol. 2021 Mar 15;155(4):506-514
pubmed: 33316056
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
Eur Respir J. 2022 Oct 6;60(4):
pubmed: 35301248
Mycoses. 2021 Oct;64(10):1223-1229
pubmed: 34157166
Arch Pathol Lab Med. 2022 Jul 1;146(7):791-804
pubmed: 35319744
J Bras Pneumol. 2022 Apr 29;48(3):e20210438
pubmed: 35508067
Diagnostics (Basel). 2022 Jan 01;12(1):
pubmed: 35054262
J Infect. 2020 Apr;80(4):401-406
pubmed: 32112886
Am J Respir Crit Care Med. 2020 Aug 15;202(4):598-599
pubmed: 32609531
Respir Res. 2023 Jun 9;24(1):152
pubmed: 37296478
Infection. 2022 Feb;50(1):263-267
pubmed: 34435313
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
Respiration. 2021;100(6):488-498
pubmed: 33725700
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
Lancet Infect Dis. 2021 Jun;21(6):e149-e162
pubmed: 33333012
J Pathol. 2021 Jun;254(2):173-184
pubmed: 33626204
Front Med (Lausanne). 2022 Feb 09;9:778489
pubmed: 35223894
Mod Pathol. 2020 Nov;33(11):2156-2168
pubmed: 32879413
BMJ. 2020 Feb 19;368:m606
pubmed: 32075786
Lancet Infect Dis. 2020 Oct;20(10):1135-1140
pubmed: 32526193
Mod Pathol. 2021 Aug;34(8):1456-1467
pubmed: 33795830
Sci Transl Med. 2020 Dec 16;12(574):
pubmed: 33257409
Histopathology. 2023 Aug;83(2):229-241
pubmed: 37102989
EClinicalMedicine. 2021 Dec;42:101209
pubmed: 34841234

Auteurs

Gheorghe-Emilian Olteanu (GE)

Center for Research and Innovation in Personalized Medicine of Respiratory Diseases, Faculty of Medicine, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.
Research Center for Pharmaco-Toxicological Evaluations, Faculty of Pharmacy, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.

Federica Pezzuto (F)

Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padova Medical School, Padova, Italy.
University Hospital of Padova, Padova, Italy.

Francesca Lunardi (F)

Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padova Medical School, Padova, Italy.
University Hospital of Padova, Padova, Italy.

Francesco Fortarezza (F)

University Hospital of Padova, Padova, Italy.

Alessandra Dubini (A)

Pathology Unit, GB Morgagni Hospital, Forlì, Italy.

Fiorella Calabrese (F)

Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padova Medical School, Padova, Italy.
University Hospital of Padova, Padova, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH